Keywords: پلی (d، l-lactide-co-glycolide); PBSBDL; poly[(butylene succinate)-co-(butylene dilinoleate)]; PLA; poly(D,L-lactide); PLGA; poly(D,L-lactide-co-glycolide); RG; radius of gyration; RH; hydrodynamic radius; Ï; RG/RH ratio; PTX; paclitaxel; d; density; dNP; density of the nanoparticles; R
مقالات ISI پلی (d، l-lactide-co-glycolide) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پلی (d، l-lactide-co-glycolide); PAE; poly(anhydride ester); PDLA; poly(D-lactide); PLLA; poly(L-lactide); PDLLA; poly(D,L-lactide); PGA; poly(glycolide); PLGA; poly(D,L-lactide-co-glycolide); PCL; poly(ε-caprolactone); PLCL; poly(L-lactide-co-ε-caprolactone); PTD-PC; desaminotyrosine
Keywords: پلی (d، l-lactide-co-glycolide); AG; agarose; AIs; active ingredients; AP; aminopyrene; AGET; activators generated by electron transfer; AgNPs; silver nanoparticles; ATRP; atom transfer radical polymerization; AuNPs; gold nanoparticles; B. subtilis; Bacillus subtilis; BD; bismaleimide; B
Keywords: پلی (d، l-lactide-co-glycolide); Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
Keywords: پلی (d، l-lactide-co-glycolide); LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
Keywords: پلی (d، l-lactide-co-glycolide); Raloxifene; Controlled drug release; Microsphere; Raloxifene-poly(ethylene glycol) conjugate; Poly(ε-caprolactone); Poly(D,L-lactide-co-glycolide)
Keywords: پلی (d، l-lactide-co-glycolide); 2D; two-dimensional; AF4; asymmetrical flow field-flow fractionation; AFM; atomic force microscopy; AMP; amylopectin; AMY; amylose; API; active pharmaceutical ingredients; AUC; analytical ultracentrifugation; BHT; butylated hydroxytoluene; BSA; bovine ser
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Bioactive glass; Composite; Freeze-drying; Bone; Tissue engineering;
Keywords: پلی (d، l-lactide-co-glycolide); GFs; growth factors; ALG; alginate; HA; hyaluronic acid; HEP; heparin; PEI; polyethyleneimine; PHEMA; poly(2-hydroxyethyl methacrylate); PEG; poly(ethylene glycol); PEO; poly(ethylene oxide); DEX; dextran; PPO; poly(propylene oxide); PPG; poly(propylene g
Keywords: پلی (d، l-lactide-co-glycolide); PLGA; poly(d,l-lactide-co-glycolide); IGF-1; insulin-like growth factor-1; NPs; nanoparticles; MI; myocardial infarction; QDs; quantum dots; EDC; 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; LVEDd; left ventricular end-diastolic dimension; LVESd; left
Keywords: پلی (d، l-lactide-co-glycolide); dex-HEMA; dextran-hydroxyethylmethacrylate carbonate derivative; DMAEMA; dimethylaminoethylmethacrylate; ECM; extracellular matrix; Gâ²; elastic modulus; Gâ³; viscous modulus; GMPs; gelatin microparticles; LCST; lower critical solubility temperature; MA
Keywords: پلی (d، l-lactide-co-glycolide); siRNA; small interfering RNA; AON; antisense oligonucleotides; shRNA; small hairpin RNA; pDNA; plasmid DNA; CYP3A; cytochrome P450 3A; MDR; multidrug resistance; MDR1; multidrug resistance protein 1; Pgp; P-glycoprotein; TRAIL; tumor necrosis factor-relat
Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil
Keywords: پلی (d، l-lactide-co-glycolide); 5-FU; 5-fluorouracil; poly(lactic/glycolic) acid (PLGA, PLA); controlled/sustained release/delivery; microparticles; nanoparticles; 5-FU; 5-fluorouracil; dUMP; deoxyuridine monophosphate; DCM; dichloromethane; EPR; enhanced permeation and retention; FdUMP
Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors
Keywords: پلی (d، l-lactide-co-glycolide); miR; micro RNA; miRi; micro RNA inhibitor; pac; paclitaxel; ER; estrogen receptor; PR; progesterone receptor; HER2/neu; epidermal growth factor receptor 2; TNBC; triple-negative breast cancer; PLGA; poly(d,l-lactide-co-glycolide); PEG; poly(ethylene-glyco
Nasal vaccination with poly(β-amino ester)-poly(d,l-lactide-co-glycolide) hybrid nanoparticles
Keywords: پلی (d، l-lactide-co-glycolide); Mucosal vaccination; Nasal delivery; Nanoparticle; Poly(β-amino ester); Poly(d,l-lactide-co-glycolide); Antibody; Cytokine;
Full length articleThe effect of particle size on the in vivo degradation of poly(d,l-lactide-co-glycolide)/α-tricalcium phosphate micro- and nanocomposites
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Tricalcium phosphate; Nanocomposite; Degradation; Segmentation;
ReviewStrategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
Keywords: پلی (d، l-lactide-co-glycolide); PLGA; poly(d,l-lactide-co-glycolide); logP; partition coefficient; Mw; molecular weight; W1/O/W2; water/oil/water; O/W; oil/water; W2; outer water phase; W1; inner water phase; S/O1/O2; solid/oil/oil; S/O/W; solid/oil/water; W/O1/O2; water/oil/oil; ME; me
Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Polyethylene glycol; Poly(allyl glycidyl ether); Vaccination; Nanomedicines; Cellular uptake;
Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors
Keywords: پلی (d، l-lactide-co-glycolide); Blank microparticles or blank liposomes; microparticles or liposomes not loaded with drug or siRNA; DC; liposomes comprising DOTAP:cholesterol in 50:50 ratio; DOPE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOTAP; 1,2-dioleoyl-3-trimethylammoniumprop
M-cell targeted polymeric lipid nanoparticles containing a toll-like receptor agonist to boost oral immunity
Keywords: پلی (d، l-lactide-co-glycolide); Oral delivery; Vaccine; Polymeric lipid nanoparticles; M-cell targeting; Toll-like receptor agonist; GI; gastrointestinal; APC; antigen-presenting cells; UEA-1; ulex europaeus agglutinin-1; NP; nanoparticle; TLR; toll-like receptor; MPL; monophosphoryl li
Mucosal application of cationic poly(d,l-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease
Keywords: پلی (d، l-lactide-co-glycolide); ChIL-2; chicken interleukin 2; CpG-ODN; oligodeoxynucleotides (ODN) containing CpG; DNA; deoxyribonucleic acid; IBDV; infectious bursal disease virus; MP; microparticles; PLGA; poly(d,l-lactide-co-glycolide); Tregs; regulatory T-cells; VP2; virus protein
Flurbiprofen PLGA-PEG nanospheres: Role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy
Keywords: پلی (d، l-lactide-co-glycolide); Flurbiprofen; Nanospheres; Poly(d,l-lactide-co-glycolide); Poly(ethylene glycol); Hydroxypropyl-β-cyclodextrin; Topical drug delivery; Skin penetration;
In vitro and in vivo evaluation of the efficacy of nanoformulation of siRNA as an adjuvant to improve the anticancer potential of cisplatin
Keywords: پلی (d، l-lactide-co-glycolide); Nanoformulations; Poly(d,l-lactide-co-glycolide); siRNA; Bcl-2 and cisplatin;
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits
Keywords: پلی (d، l-lactide-co-glycolide); Melatonin; Glaucoma; IOP; Ocular drug delivery systems; Poly(d,l-lactide-co-glycolide); Cryoprotector; PLGA-PEG
Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity
Keywords: پلی (d، l-lactide-co-glycolide); Antitumor drug; Double emulsion/solvent evaporation; Flow Focusing®; Gemcitabine; Nanoparticles; Poly(d,l-lactide-co-glycolide)
Production of biodegradable porous scaffolds impregnated with 5-fluorouracil in supercritical CO2
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide); Poly(d,l-lactide-co-glycolide); 5-Fluorouracil; Tissue engineering; Foams; Supercritical CO2
Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53–MDM2 interaction
Keywords: پلی (d، l-lactide-co-glycolide); Antitumor; Poly(d,l-lactide-co-glycolide); Polymeric nanoparticles; Xanthones
Production of biodegradable porous scaffolds impregnated with indomethacin in supercritical CO2
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide); Poly(d,l-lactide-co-glycolide); Indomethacin; Tissue engineering; Foams; Supercritical CO2
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration
Keywords: پلی (d، l-lactide-co-glycolide); Nanoparticles; Poly(d,l-lactide-co-glycolide); Chitosan; Insulin; Oral administration
In vitro bioactivity of chitosan/poly (d,l-lactide-co-glycolide) composites
Keywords: پلی (d، l-lactide-co-glycolide); Bioactive materials; Chitosan; Poly(d,l-lactide-co-glycolide); SBF
Effect of copolymer ratio on hydrolytic degradation of poly(lactide-co-glycolide) from drug eluting coronary stents
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Hydrolytic degradation; Restenosis; Drug eluting stent
Pore formation and pore closure in poly(D,L-lactide-co-glycolide) films
Keywords: پلی (d، l-lactide-co-glycolide); Pore closure; Poly(D,L-lactide-co-glycolide); Mechanism; Diffusion; Degradation;
Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Hepatitis B virus; Gene therapy; Chitosan; Nanoparticles
Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(d,l-lactide-co-glycolide) nanospheres for inflammatory bowel disease
Keywords: پلی (d، l-lactide-co-glycolide); poly(d,l-lactide-co-glycolide); Chitosan; NF-kB decoy oligonucleotide; Oral delivery system; Ulcerative colitis; Nanosphere
Photochemical internalization for pDNA transfection: Evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles
Keywords: پلی (d، l-lactide-co-glycolide); Gene delivery; Nanoparticles; Photochemical internalization; Poly(d,l-lactide-co-glycolide); Polyethylenimine;
The influence of the compounding process and testing conditions on the compressive mechanical properties of poly(D,L-lactide-co-glycolide)/αα-tricalcium phosphate nanocomposites
Keywords: پلی (d، l-lactide-co-glycolide); Poly(D,L-lactide-co-glycolide); Nanocomposite; Compressive modulus; Glass transition temperature; Degradation
Development of mass transport resistance in poly(lactide-co-glycolide) films and particles – A mechanistic study
Keywords: پلی (d، l-lactide-co-glycolide); Diffusion; Transport resistance; Pore closure; Poly(d,l-lactide-co-glycolide); Release mechanism; Degradation
Mechanistic study of hydrolytic erosion and drug release behaviour of PLGA nanoparticles: Influence of chitosan
Keywords: پلی (d، l-lactide-co-glycolide); Erosion; Chitosan; Nanoparticles; Drug release; Poly(d,l-lactide-co-glycolide);
Efficacy of a new sustained-release microsphere formulation of exenatide, DA-3091, in Zucker diabetic fatty (ZDF) rats
Keywords: پلی (d، l-lactide-co-glycolide); GLP-1 agonist; Exenatide; Sustained-release formulation; Poly(d,l-lactide-co-glycolide); Zucker diabetic fatty (ZDF) rats; Type 2 diabetes mellitus
Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents
Keywords: پلی (d، l-lactide-co-glycolide); Nanoparticle; MRI (magnetic resonance imaging); Surface modification; Poly(d,l-lactide-co-glycolide); Gadolinium; Chelate
Development of a sustained-release recombinant human growth hormone formulation
Keywords: پلی (d، l-lactide-co-glycolide); Protein delivery; Sustained-release formulation; Recombinant human growth hormone; Poly(D,L-lactide-co-glycolide); Solvent evaporation
Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Degradation; Stability; In situ forming depot
Mathematical modelling of the solubility of supercritical CO2 in poly(l-lactide) and poly(d,l-lactide-co-glycolide)
Keywords: پلی (d، l-lactide-co-glycolide); Sanchez–Lacombe equation of state; PC-SAFT; Poly(l-lactide); Poly(d,l-lactide-co-glycolide); Supercritical CO2; Solubility
Encapsulated zinc salt increases the diffusion of protein through PLG films
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Diffusion; Degradation; Pore formation; Zinc salt; Controlled release
hGH release from directly compressed hGH-PLGA biodegradable implantable tablets: Influence of physicomechanical factors
Keywords: پلی (d، l-lactide-co-glycolide); Implantable tablet; Poly(d,l-lactide-co-glycolide); Human growth hormone; Porosity; Rheometry
Polymeric nanoparticles for siRNA delivery and gene silencing
Keywords: پلی (d، l-lactide-co-glycolide); RNA interference; siRNA; poly(d,l-lactide-co-glycolide); Luciferase; Sustained release
Preparation of polyethyleneimine incorporated poly(d,l-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Polyethyleneimine; Nanoparticles; siRNA; Gene silencing
Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery
Keywords: پلی (d، l-lactide-co-glycolide); Poly(d,l-lactide-co-glycolide); Nanosphere; Chitosan; Emulsion solvent diffusion method; pDNA; Antisense oligonucleotide; siRNA
Amphotericin B-incorporated polymeric micelles composed of poly(d,l-lactide-co-glycolide)/dextran graft copolymer
Keywords: پلی (d، l-lactide-co-glycolide); Amphotericin B; Dextran; Polymeric micelle; Poly(d,l-lactide-co-glycolide); Candida albicans
A detailed analysis of biodegradable nanospheres by different techniques—A combined approach to detect particle sizes and size distributions
Keywords: پلی (d، l-lactide-co-glycolide); Nanoparticles; Poly(d,l-lactide-co-glycolide); Particle size distribution; Flow field-flow fractionation; Small-angle X-ray scattering; Photon correlation spectroscopy; Poloxamer